Understanding Risk Factors for Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Insights From a 10‐Year Study Comparing Conditioning Regimens
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.70093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Tuğba Erat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Infectious Diseases, Ankara Bilkent City Hospital, Health Sciences University, Ankara, Turkey. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Transplantation Conditioning. Die Arbeit nennt 34 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Hematopoietic stem cell transplantation is a curative therapy for pediatric patients with malignancies and blood or immune system disorders. However, recipients are at risk of opportunistic infections, including cytomegalovirus infection, due to immunosuppression from conditioning regimens. This retrospective study analyzed 439 pediatric hematopoietic stem cell transplantation patients to identify risk factors for cytomegalovirus infection and assess the impact of conditioning regimens. Significant factors included graft source, graft versus host disease, and pre‐transplant clinically significant cytomegalovirus infection. Myeloablative conditioning regimens and the use of anti‐thymocyte globulin increased the risk of clinically significant cytomegalovirus infection. Additionally, the risk of cytomegalovirus infection in patients was found to be statistically significant in the myeloablative subgroup analyses who received anti‐thymocyte globulin alone and those who received both anti‐thymocyte globulin and total body irradiation. In our study, total body irradiation did not significantly affect the risk of clinically significant cytomegalovirus infection. This study covers a 10‐year period and a large pediatric patient population from a single center. Our findings highlight the importance of understanding risk factors for clinically significant cytomegalovirus infection to guide preventive strategies in pediatric HSCT recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Infectious Diseases, Ankara Bilkent City Hospital, Health Sciences University, Ankara, Turkey.
- Department of Pediatric Hematology/Oncology and Pediatric Bone Marrow Transplantation Unit, Ankara Bilkent City Hospital, Health Sciences University, Ankara, Turkey.
- Department of Pediatric Infectious Diseases, Ankara Bilkent City Hospital, Yıldırım Beyazıt University, Ankara, Turkey.
ORCID-Profile: Tuğba Erat, İkbal Ok Bozkaya, Özlem Mustafaoğlu, Şerife Mehtap Kanbur, Belgin Gülhan, Saliha Kanık-Yüksek, Aslınur Özkaya-Parlakay, Namık Yaşar Özbek
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Erat, T., Bozkaya, İ. O., Mustafaoğlu, Ö., Kanbur, Ş. M., Gülhan, B., Kanık-Yüksek, S., Özkaya-Parlakay, A., & Özbek, N. Y. (2024). Understanding Risk Factors for Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Insights From a 10‐Year Study Comparing Conditioning Regimens. Journal of Medical Virology. https://doi.org/10.1002/jmv.70093
Vancouver
Erat T, Bozkaya İO, Mustafaoğlu Ö, Kanbur ŞM, Gülhan B, Kanık-Yüksek S, et al. Understanding Risk Factors for Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Insights From a 10‐Year Study Comparing Conditioning Regimens. Journal of Medical Virology. 2024. doi:10.1002/jmv.70093
BibTeX
@article{Erat2024,
author = {Erat, Tuğba and Bozkaya, İkbal Ok and Mustafaoğlu, Özlem and Kanbur, Şerife Mehtap and Gülhan, Belgin and Kanık-Yüksek, Saliha and Özkaya-Parlakay, Aslınur and Özbek, Namık Yaşar},
title = {Understanding Risk Factors for Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Insights From a 10‐Year Study Comparing Conditioning Regimens},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.70093}
}
EUVIMED